The term “metabolic syndrome” is used to describe the conjunction of abdominal obesity with hypertension, dislipemia and insulin resistance, which generally meets with endotelial malfunction, one of the first events that take place in the development of aterosclerosis. The obesity is considered, in fact, a low-grade chronic inflammatory process, since it is characterized by an increase in inflammation markers produced by adipocytes, such as C-reactive protein, tumor necrosis factor alpha, interleukin-6 and even the macrophage infiltration in the adipose tissue. In obesity, an increase in reactive oxygen species is observed, which increase proinflammatory activation pathways. Hypertrigliceridemia attributable to the increase of triglyceride-rich lipoproteins (TRL) is the most invariable metabolic alteration in obesity.
See References
No comments:
Post a Comment